4,032 Shares in Chemed Corporation $CHE Acquired by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio acquired a new position in Chemed Corporation (NYSE:CHE) during the second quarter, Holdings Channel.com reports. The firm acquired 4,032 shares of the company’s stock, valued at approximately $1,878,000.

Several other institutional investors also recently bought and sold shares of CHE. Quantbot Technologies LP purchased a new position in Chemed in the second quarter valued at $1,726,000. The Manufacturers Life Insurance Company acquired a new position in shares of Chemed during the second quarter valued at approximately $4,413,000. TD Asset Management Inc lifted its stake in Chemed by 7.5% in the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after purchasing an additional 22,715 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after acquiring an additional 4,430 shares during the period. Finally, Epoch Investment Partners Inc. lifted its stake in shares of Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after purchasing an additional 15,133 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Trading Up 0.2%

Shares of CHE opened at $520.82 on Monday. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The firm has a market capitalization of $6.81 billion, a P/E ratio of 26.16, a PEG ratio of 1.97 and a beta of 0.51. The firm’s 50-day moving average is $516.70 and its two-hundred day moving average is $451.67. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. During the same period in the previous year, the firm posted $4.27 earnings per share. Chemed’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts predict that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Monday, August 17th were given a dividend of $0.70 per share. The ex-dividend date was Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is presently 14.06%.

Wall Street Analysts Forecast Growth

CHE has been the subject of several recent research reports. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Royal Bank Of Canada upped their price target on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Finally, Oppenheimer upped their price objective on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $530.75.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the transaction, the chief executive officer owned 70,418 shares of the company’s stock, valued at $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the transaction, the director owned 3,533 shares of the company’s stock, valued at $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.